Видео с ютуба Sunlenca Trial

How Does Lenacapavir (Sunlenca) for HIV Work?

How Does Lenacapavir (Sunlenca) for HIV Work?
Ленакапавир (Сунленка) — инъекции два раза в год для лечения ВИЧ-инфекции.

Ленакапавир (Сунленка) — инъекции два раза в год для лечения ВИЧ-инфекции.
Long-Acting Impact: From PURPOSE to Practice with Lenacapavir

Long-Acting Impact: From PURPOSE to Practice with Lenacapavir
Sunlenca shots tested for HIV prevention

Sunlenca shots tested for HIV prevention
New HIV Infection Clinical Trial: Oral Lenacapavir for Pre-Exposure Prophylaxis of HIV Infection

New HIV Infection Clinical Trial: Oral Lenacapavir for Pre-Exposure Prophylaxis of HIV Infection
Drug trial shows injection twice a year is 100% effective against infection

Drug trial shows injection twice a year is 100% effective against infection
Talking to patients about Lenacapavir (Sunlenca); the new long-acting injectable medication for HIV

Talking to patients about Lenacapavir (Sunlenca); the new long-acting injectable medication for HIV
Single Daily Tablet Shows Powerful Results for People With Drug-Resistant HIV!

Single Daily Tablet Shows Powerful Results for People With Drug-Resistant HIV!
HIV Treatment Breakthrough Once Weekly ISLATRAVIR - LENACAPAVIR Trials

HIV Treatment Breakthrough Once Weekly ISLATRAVIR - LENACAPAVIR Trials
Sunlenca (lenacapavir)- treatment of HIV-1 infection #hiv #infection #gilead

Sunlenca (lenacapavir)- treatment of HIV-1 infection #hiv #infection #gilead
Understanding Genomics - Sunlenca -HIV vaccine - Episode 7

Understanding Genomics - Sunlenca -HIV vaccine - Episode 7
First Twice-Yearly HIV Prevention Shot FDA Approved

First Twice-Yearly HIV Prevention Shot FDA Approved
Clinical trial Capsid Inhibition with Lenacapavir in Multidrug Resistant HIV 1 Infection

Clinical trial Capsid Inhibition with Lenacapavir in Multidrug Resistant HIV 1 Infection
Latest on Lenacapavir HIV 1: Sunlenca or Yeztugo

Latest on Lenacapavir HIV 1: Sunlenca or Yeztugo

HEALTH | Breakthrough on HIV/Aids Trials: In conversation with Prof Linda-Gail Bekker

HEALTH | Breakthrough on HIV/Aids Trials: In conversation with Prof Linda-Gail Bekker
Breakthrough in HIV prevention with lenacapavir

Breakthrough in HIV prevention with lenacapavir
LENACAPAVIR: A TWICE‑YEARLY OPTION (WHAT TRIALS SHOW)

LENACAPAVIR: A TWICE‑YEARLY OPTION (WHAT TRIALS SHOW)
Gravitas: Lenacapavir injection found effective in preventing HIV | World News | WION

Gravitas: Lenacapavir injection found effective in preventing HIV | World News | WION
Gilead's Once Yearly Lenacapavir Formulations Show Sustained Efficacy for HIV PrEP in Phase 1 Study

Gilead's Once Yearly Lenacapavir Formulations Show Sustained Efficacy for HIV PrEP in Phase 1 Study